Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.4926
-0.0323 (-6.16%)
Jan 16, 2026, 4:00 PM EST
Aspira Women's Health Revenue
Aspira Women's Health had revenue of $2.31M in the quarter ending September 30, 2025, with 2.13% growth. This brings the company's revenue in the last twelve months to $9.34M, up 4.17% year-over-year. In the year 2024, Aspira Women's Health had annual revenue of $9.18M with 0.31% growth.
Revenue (ttm)
9.34M
Revenue Growth
+4.17%
P/S Ratio
2.29
Revenue / Employee
141.47K
Employees
66
Market Cap
21.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.18M | 28.00K | 0.31% |
| Dec 31, 2023 | 9.15M | 970.00K | 11.85% |
| Dec 31, 2022 | 8.18M | 1.37M | 20.14% |
| Dec 31, 2021 | 6.81M | 2.16M | 46.46% |
| Dec 31, 2020 | 4.65M | 113.00K | 2.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |
Aspira Women's Health News
- 2 months ago - Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update - Accesswire
- 2 months ago - Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston - Accesswire
- 4 months ago - Aspira Women's Health Announces Equity Capital Infusion of $3.06 Million in Private Placement and Warrant Exercise - Accesswire
- 4 months ago - Aspira Women's Health Appoints New Chief Financial Officer - Accesswire
- 5 months ago - Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update - Accesswire
- 6 months ago - Aspira Women's Health Announces Appointment of Jane Pine Wood to the Board of Directors - Accesswire
- 7 months ago - Aspira Women's Health Partners with Dorsata to Offer Access to 300+ Women's Health Practices, 1.5 Million + New Patients - Accesswire
- 7 months ago - Aspira Women's Health Provides Update on ARPA-H Sprint Program Partnership to Advance Women's Health - Accesswire